Serina Therapeutics Announces Date for 2025 Annual Stockholders Meeting
(NYSE MKT:SER), HUNTSVILLE, July 01, 2025 (GLOBE NEWSWIRE) — Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company, today announced that its Board of Directors has established November 7, 2025, as the date of its 2025 annual meeting of stockholders (the “Annual Meeting”). The time and location of the Annual Meeting will be […]